Evidence map›Paper›PMID 39596707›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Preclinical Validation of MIN-T: A Novel Controlled-Released Formulation for the Adjunctive Local Application of Minocycline in Periodontitis.

Małgorzata Benedyk-Machaczka, Piotr Mydel, Karsten Mäder, Marta Kaminska, Nadine Taudte, Marcel Naumann, Martin Kleinschmidt, Sandra Sarembe, Andreas Kiesow, Sigrun Eick and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Małgorzata Benedyk-MachaczkaH&G Ltd., 31-431 Krakow, Poland.
Piotr MydelH&G Ltd., 31-431 Krakow, Poland.
Karsten MäderInstitute of Pharmacy, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle (Saale), Germany.ORCID 0000-0003-1613-6976
Marta KaminskaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Nadine TaudtePerioTrap Pharmaceuticals GmbH, Weinbergweg 22, 06120 Halle (Saale), Germany.
Marcel NaumannDepartment Drug Design and Analytical Chemistry, Fraunhofer IZI-MWT, Weinbergweg 22, 06120 Halle (Saale), Germany.ORCID 0000-0001-7869-3212
Martin KleinschmidtDepartment Drug Design and Analytical Chemistry, Fraunhofer IZI-MWT, Weinbergweg 22, 06120 Halle (Saale), Germany.ORCID 0000-0002-2128-9101
Sandra SarembeDepartment Biological and Macromolecular Materials, Fraunhofer Institute for Microstructure and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.
Andreas KiesowDepartment Biological and Macromolecular Materials, Fraunhofer Institute for Microstructure and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.
Sigrun EickDepartment of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, CH-3010 Bern, Switzerland.ORCID 0000-0002-4619-2461
Mirko BuchholzPerioTrap Pharmaceuticals GmbH, Weinbergweg 22, 06120 Halle (Saale), Germany.ORCID 0000-0002-2629-4153

Funding

Investitionsbank Sachsen-Anhalt 2104/00044 and 2104/00048
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjunctive therapybiodegradationcontrolled releaselocal applicationminocyclinenon-clinicalperiodontitisproof-of-conceptresistance

Identifiers

PMID39596707
PMCPMC11591261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.